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A best evidence topic was written according to a structured protocol. In [patients with primary oeso-
phageal achalasia] is [laparoscopic Heller Myotomy] superior to [endoscopic dilatation] with respect to
[clinical outcomes]. In total 49 papers were found using the reported search, and eight of these repre-
sented the best evidence to answer the clinical question. The authors, date, journal, study type, popu-
lation, main outcome measures and results are tabulated. Existing evidence shows that LHM is associated
with improved post-operative symptoms and reduced clinical relapse rates compared to ED. Satisfactory
clinical outcomes with ED often require repeat procedures performed over time and are associated with
an increased risk of oesophageal perforation compared to LHM. One prospective randomized study
showed no signiﬁcant difference in post-operative outcomes between LHM and ED but this was limited
by lack of standardization in the endoscopic dilatation procedure, limited reporting of complications and
poor long-term follow up. Current evidence shows oesophageal perforation during LHM may be suc-
cessfully managed intra-operatively but in ED usually requires further laparoscopic or open operative
intervention. Fundoplication during LHM is associated with reduced incidence of post-operative gastro-
oesophageal reﬂux disease. There is an increased risk of clinical relapse regardless of the treatment in
patients with a sigmoid-shaped oesophagus or reduced oesophageal sphincter pressure assessed during
pre-treatment manometry. Current studies are limited by study design, variations in operative technique
and dilatation regimens, and limited follow up times. Further higher power studies matching patients for
disease severity and surgical technique with longer follow up may enable greater understanding of
differences in outcomes and improved patient selection for different treatment regimens.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol. The protocol is fully described in the International Journal
of Surgery.1
2. Three-part question
In [patients with primary oesophageal achalasia] is [laparo-
scopic Heller Myotomy] superior to [endoscopic dilatation] with
respect to [clinical outcomes].
3. Clinical scenario
A patient with primary oesophageal achalasia not responding to
medical therapy is referred to the surgical clinic for furtherfax: þ44 (0)20 331 26950.
charakis).
ciates Ltd. Published by Elsevier Ltmanagement with endoscopic dilatation (ED) or laparoscopic
Heller Myotomy (LHM). A visiting professor from Greece cites the
risk of recurrence and perforation with ED and advises LHM. You
decide to search the literature to determine if there are any sig-
niﬁcant differences in clinical outcomes in primary oesophageal
achalasia treated with ED and LHM.
4. Search strategy
A Medline search from January 1950 to December 2012 was
performed using OVIDSP interface (exp achlasia OR car-
diospasm.mp OR oesophageal aperistalsis.mp) AND (exp. Heller
Myotomy OR pneumatic dilatation.mp or balloon dilatation.mp).
References were also retrieved from key articles and reviewed.
5. Search outcome
The described literature search identiﬁed 49 articles for review
and four articles were selected from the references and relatedd. All rights reserved.
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reviewed and 23 articles excluded as they were not relevant to the
clinical question. Of these remaining 30 studies a further 22 studies
were excluded: eight studies did not compare LHM and ED, seven
studies pooled results for open and laparoscopic myotomy, and
seven studies did not present clinical outcomes. Eight studies were
identiﬁed as presenting the best evidence to the clinical question
and included in this study. These are studies are shown in Table 1.
6. Results
Wang et al.2 conducted a meta-analysis comparing outcomes in
761 patients in 17 separate randomized controlled trials following
treatment with pharmacological therapy, botulinum injection, ED
and LHM. Two studies were identiﬁed which compared outcomes
between ED (n¼ 42) and LHM (n¼ 39) with symptoms scored pre-
operatively and post-operatively. This study showed LHM was
associated with increased remission rates (RR¼ 1.48, 95% CI 1.48e
1.87) and reduced clinical relapse rates (RR¼ 0.14, 95% CI 0.04e
0.58) compared to ED. There was no signiﬁcant difference be-
tween LHM and ED with respect to post-operative complications
(RR¼ 1.48, 95% CI 0.37e5.99). In this study, only two randomized
studies were used to perform the meta-analysis between ED and
LHM, randomization methods were unclear and patients under-
going LHM were not matched for the fundoplication procedures.
Campos et al.3 conducted a systematic review andmeta-analysis
comparing achalasia treatment with botulinum injection, ED, and
LHM with respect to post-operative symptoms, prevalence of
gastro-oesophageal reﬂux disease and complications. A total of 105
articles reporting on 7855 patients were selected and reviewed.
LHM was associated with improved post-operative symptoms
compared to ED at 12months (68.2% vs. 89.3%, respectively; OR 3.7;
95% CI, 2.3e6.0; P< 0.01) and after 36 months (56.3% vs. 89.3%,
respectively; OR 5.9; 95% CI 3.7e9.3; P< 0.01). There was no dif-
ference in the overall complication rate between LHM and ED (6.3%
vs. 8.8%, respectively; OR 0.8; 95% CI 0.6e1.1; P¼ 0.2). The incidence
of gastro-oesophageal reﬂux was signiﬁcantly reduced when the
LHM was combined with a fundoplication procedure (31.5%
without a fundoplication vs. 8.8% with; OR 6.3; 95% CI 2.0e19.4;
P¼ 0.003). This study was limited due to poor standardization of
operative and endoscopic treatment methodology, variations in
follow up times and limited reporting of post-operative
complications.
Boeckxstaens et al.4 conducted a prospective, randomized trial
comparing outcomes between ED (n¼ 95) and LHM (n¼ 106).
Outcomes recorded included pre and post-operative symptoms as
assessed by Eckardt scoring, oesophageal pressure assessed on
manometry, gastric emptying evaluated through barium-contrast
enema, quality of life and complications for a period of 43
months (95% CI 40e47) following surgery. This study found no
signiﬁcance difference between LHM and ED with respect to post-
operative symptoms, oesophageal pressure, gastric motility, quality
of life or complications. Oesophageal perforation occurred in 4
patients (4%) undergoing ED, which were treated with conservative
management in 2 patients and surgical correction in 2 patients.
Mucosal injury was observed in 13 patients (12%) undergoing LHM
and this was treated with immediate intra-operative correction in
12 patients and conversion to open surgery in one patient. Major
limitations of this study were the high perforation rates in the ﬁrst
group of patients treated with ED (4 of ﬁrst 13 patients, 31%) and
the subsequent exclusion of these patients from the analysis
comparing outcomes between ED and LHM.
Kostic et al.5 conducted a prospective, randomized trial
comparing outcomes in newly diagnosed achalasia treated with ED
(n¼ 26) and LHM with posterior partial fundoplication (n¼ 25).The ED protocol comprised a two-stage procedure under direct
ﬂuoroscopy with an interval of seven to ten days. The LHM con-
sisted of a complete antrerior myotomy and incomplete posterior
fundoplication. Patients were followed up for 12 months following
the procedure. Patients undergoing LHM (4%, n¼ 1) had signiﬁ-
cantly reduced treatment failures compared to ED (4% vs. 23%,
respectively, P¼ 0.04). There was no signiﬁcant difference between
the two groups relating to post-operative symptoms or quality of
life scores. In this study, the study size was small, there was no
long-term follow up and limited information is presented about the
experience of the surgeons performing LHM.
Novais et al.6 performed a prospective, randomized study
comparing clinical/manometric results and 24-h pH monitoring in
patients undergoing ED (n¼ 47) and LHM (n¼ 47) with fundoplica-
tion in patients with achalasia. Patients were followed up for clinical
response, manometric response and 24-h pH monitoring for three
months after treatment. This study showed that ED was associated
with signiﬁcantly increased gastro-oesophageal reﬂux on 24-h pH
testing (4.7% LMH vs. 31% ED, P¼ 0.001) and associated with a hy-
potensive lower gastro-oesophageal sphincter. A 24-h pH suggestive
of fermentation or true reﬂuxwasnot associatedwithworse clinical/
manometric results. This study did not account for co-morbidities
(e.g. obesity) impacting on reﬂux and had short follow up times
and so correlation to long-term relapse rates was not possible.
Vela et al.7 conducted a retrospective cohort study comparing
long-term outcomes between ED (n¼ 106) and LHM (n¼ 73) for
achalasia and investigated risk factors associated with treatment
failure. Patients undergoing ED underwent one to three progres-
sively larger dilatations and those patients which failed to respond
to ED (n¼ 20) were treated with LHM. Endoscopy, manometry, and
timed barium studies were performed to determine the case of
treatment failure. This study showed no signiﬁcant difference be-
tween ED and LHMwith respect to clinical symptoms at six months
and six years. The incidence of recurrence increased over time with
both groups and was associated with incompletely treated acha-
lasia and gastro-oesophageal reﬂux disease. This was a retrospec-
tive study in which patients received varying frequencies of ED
with potential selection bias as patients with complex refractory
disease not responding to ED were switched to the LHM group.
Gutschow et al.8 conducted a retrospective study on 43 patients
with achalasia comparing clinical outcomes between endoscopic
botulinum injection (EBTI¼ 7), endoscopic balloon dilatation
(PD¼ 17), surgical myotomy after failed balloon dilatation (PD-
LHM¼ 14) and ﬁrst-line laparoscopic Heller’s myotomy (LHM¼ 6).
All procedures were performed in a single institution and patients
were assessed using standardized symptom scores pre-operatively
and at follow up. First-line LHM was associated with improved
clinical remission rates compared to SD (83.3 vs. 50%, respectively).
Overall, low esophageal sphincter pressure during pre-treatment
manometry (P¼ 0.03) and sigmoid-shaped oesophagus (P¼ 0.06)
were identiﬁed as predictive factors of poorer outcome, irre-
spectively of treatment received. In this retrospective study pa-
tients were not matched for number of procedure prior to
treatment, most patients underwent pre-treatment ED and long-
term follow up data is not presented.
Reynoso et al.9 conducted a retrospective observational study
including 1882 hospitalized patientswho underwent LM (1390) and
PD (492) during a 3-year period. Datawas collected from a database
of more than 100 medical centers and nearly 200 afﬁliate hospitals.
Overall, LHM was associated with increased morbidity (50.48% vs.
19.57%, respectively; P< 0.001) and length of hospital stay
compared to ED (8.96 7.86 vs. 11.7211.05 days, respectively;
P¼ 0.04). Oesophageal perforation rate was signiﬁcantly increased
in patients undergoing ED (0.4% vs. 2.4%, respectively; P< 0.001).
Data regarding clinical remission andquality of lifewas not available
Table 1
A table showing the studies included in the best evidence topic comparing outcomes between laparoscopic Heller's myotomy and endoscopic dilatation.
Author, date, journal
and country
Patient group Study type (level of
evidence)
Outcomes Key results Comments
Wang et al., 2009,
Digestive Diseases
and Sciences, China2
Meta-analysis compared
outcomes following
pharmacological therapy,
botulinum toxin, ED and
myotomy for achalasia.
Study included 17 randomized
controlled trials with 761
patients in total.
Study included two
randomized controlled trials
that speciﬁcally compared LHM
(n¼ 39) and ED (n¼ 42).
Authors searched electronic
databases for randomized
controlled trials to evaluate
which therapeutic measures
are temporary and reversible
and which measures are
deﬁnitive and effective by
pooling data including
remission rate, relapse rate,
complications, and adverse
effects
Meta-analysis of
randomized
controlled trials
(level 1a)
Remission rate
Relapse rate
Adverse effects
Complications
LHM vs. ED
95% vs. 77.8%, P¼ 0.001
(RR¼ 1.48, 95%
CI¼ 1.16e1.87)
5.1% vs. 35.71%,
P¼ 0.007 (RR¼ 0.14,
95% CI¼ 0.04e0.58)
Results were assessed
using descriptive
statistics due to
inadequate data
Adverse effects
reported for both LHM
and ED were dysphagia
and heartburn.
No difference in
complication rate
Authors reach the conclusion
that laparoscopic Heller's
myotomy is superior to
pneumatic dilatation with
respect to clinical remission,
relapse rate and safety.
Authors report no difference
between LHM and ED with
respect to post-operative
complications.
Limitations:
Study included two
randomized trials comparing
outcomes between LHM
and ED.
Limited long-term follow up.
Patients not matched for
fundoplication procedure.
Campos et al., 2009,
Annals of Surgery,
Austria e USA3
Systemic review and meta-
analysis comparing outcomes
for achalasia with botulinum,
ED and LHM. Study included
105 articles reporting on 105
patients.
Amongst these studies 39
articles referred to LHM with
3086 patients and a mean
follow up time of 35.4 months
(range, 8e83).
Clinical outcomes recorded
included post-operative
symptoms, gastro-oesophageal
reﬂux disease, and
complications.
Systematic review
and meta-analysis
(level 1b)
Symptoms
improvement
Perforation
with clinical
manifestation
LHM vs. ED
12 months follow up:
89.3% vs. 68.2%,
P< 0.01,
36 months follow up:
89.3% vs. 56.3%, P< 0.01
0.7% vs. 1.6%, P¼ 0.14
Authors comment LHM
compared with improved post-
operative symptoms and at 12
and 36 months.
No difference between groups
with respect to post-operative
complications.
Limitations:
Poor standardization of
operative and endoscopic
treatment methodology and,
variations in follow up times.
Boeckxstaens et al.,
2011, New England
Journal of Medicine,
Multi-centre
European study4
Prospective randomized trial
(n¼ 201) comparing pneumatic
dilatation (n¼ 95) and
laparoscopic Heller's myotomy
with Dor's fundoplication
(n¼ 106) as treatment options
for achalasia.
In total 201 patients with newly
diagnosed achalasia and a pre-
intervention Eckardt symptom
score of greater than 3 were
analyzed.
Dilatation protocol consisted of
at least two consequent
interventions and a maximum
of three.
Surgical intervention was a
laparoscopic Heller's myotomy
with partial anterior
fundoplication.
Mean follow up time was 43
months.
Twenty-four-hour pH-metry
was performed at one-year
follow up.
Prospective
randomized
controlled trial
(level 2)
Primary:
therapeutic
success
(deﬁned as a
reduction in
Eckardt score
to 3).
Secondary:
pressure at the
LOS (mean
mm Hg).
Oesophageal
emptying
(median height
of barium-
contrast
column after
5 min in cm).
Quality of life
(mean score).
Rate of
complications
Abnormal
exposure to
gastric acid
(deﬁned as pH
< 4 from 5 to
23% of the
time).
LHM vs. ED
93% vs. 90% (1st year),
90% vs. 86% (2nd year),
P¼ 0.46.
LHM vs. ED
10 mmHg vs.
12 mmHg, P¼ 0.27.
0 cm vs. 0 cm (1st year),
P¼ 0.95.
1.9 cm vs. 3.7 cm (2nd
year), P¼ 0.21.
13 vs. 15 (1st year),
P¼ 0.28.
Oesophageal
perforation 4/95 (4%)
patients with PD.
Mucosal tears 13/106
(12%) patients with
LHM.
23% vs. 15%, P¼ 0.28.
Authors conclude that LHM
does not provide superior
therapeutic outcome compared
with ED at two years follow up.
Symptoms and quality of life
were assessed according to
Eckardt score and quality of life
questionnaires.
Clinical response was also
evaluated via oesophageal
manometry and timed barium
oesophagogram pre- and post-
treatment.
Overall numerical trend
favoring LHM did not reach
statistical signiﬁcance.
Limitations:
Initial dilatation protocol had
high perforation rate in ED and
these patients were excluded
from study. No long-term
follow up.
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Table 1 (continued )
Author, date, journal
and country
Patient group Study type (level of
evidence)
Outcomes Key results Comments
S. Kostic et al., 2007,
World Journal of
Surgery, Sweden5
Study including 51 patients
with newly diagnosed achalasia
treated in a single center from
January 2000 to May 2005.
Twenty-six (26) randomly
allocated to ED and 25 to LHM.
Patients were prospectively
followed up for 12 months
post-intervention.
ED was administered via a
speciﬁc two-procedure
protocol with an interval of 7
e10 days between
interventions.
Laparoscopic Heller's myotomy
was combined with a partial
posterior fundoplication.
Treatment failure was deﬁned
as incomplete symptom control
or symptom relapse clinically
indicating the need for further
or alternative intervention.
Oesophageal manometry at 12
months was limited to 7/25
patients from the LHM group
and 10/26 from PD group due to
patients' refusal to attend
follow up.
Prospective
randomized
controlled trial
(level 2)
Primary:
cumulative
number of
treatment
failures in the
ﬁrst 12 months.
Secondary:
symptoms
improvement
(mean Watson
dysphagia
score).
Quality of life
(psychological
well-being
index e higher
score indicating
better well-
being).
LHM vs. ED:
1/25 vs. 6/26, P¼ 0.04
11.3 2.35 vs.
17.7 2.69, P¼NS
From 84 20 to
101 16 vs. 92 20 to
105 19, P¼NS
Authors conclude that
laparoscopic Heller's myotomy
is a more effective treatment
than pneumatic dilatation as it
presented less treatment
failures that the dilatation
protocol.
In addition, patients were
followed up at 1, 3, 6 and 12
months via a structured
interview regarding disease
speciﬁc symptoms (Watson
dysphagia score e
gastrointestinal symptom
rating scale) and quality of life
(psychological well-being
index).
Both modalities demonstrate
improvement in quality of life
and disease speciﬁc symptoms,
but the numerical superiority of
LHM does not reach statistical
signiﬁcance.
Limitations:
Small number of patients
analyzed.
Short-term follow up.
Failure to obtain adequate
manometric or radiological
evaluation for a substantial
number of patients.
Novais et al, 2010,
Alimentary
Pharmacology
Therapeutics,
Brazil6
From June 2005 to June 2009,
85 patients with newly
diagnosed achalasia were
randomized to ED (n¼ 42) and
LHM with partial anterior
fundoplication (n¼ 43).
There were no signiﬁcant
differences between the two
groups in terms of demographic
data, mean lower oesophageal
sphincter pressure and 24-h pH
monitoring prior to therapeutic
intervention.
ED was implicated through a
progressive dilatation protocol
within the same therapeutic
session and LHMwas combined
with a partial anterior
fundoplication.
Prospective
randomized
controlled trial
(level 2)
Clinical
therapeutic
success
Incidence of
true GORD
Incidence of 24-
h pH suggestive
of fermentation
LOS pressure
(mean)
LOS pressure
drop >50%
baseline
Incidence of
hypotensive
LOS
LHM vs. ED
88.3% vs. 73.8%, P¼ 0.08
2/43 (4.7%) vs. 13/42
(31%), P¼ 0.0001.
1/43 (2.3%) vs. 6/42
(14.2%)
15.2 mmHg vs.
14.7 mmHg, P¼ 0.44.
53.4% vs. 45.2%, P¼ not
statistically signiﬁcant
16.3% vs. 35.7%,
P¼ 0.04.
Clinical therapeutic success was
numerically superior in the
LHM group but did not reach
statistical signiﬁcance.
True gastro-oesophageal reﬂux
disease was higher in patients
treated with ED and positively
correlated with hypotensive
LOS post-treatment
Limitations:
Short-term follow up did not
allow potential correlation
between symptomatic success
and manometric results.
Vela et al., 2006, Clinical
Gastroenterology
and Hepatology,
USA7
Retrospective study including
records of 106 achalasia
patients treated with graded ED
and 73 patients treated with
HM from 1994 to 2002.
All patients underwent ED with
a graded approach, consisting
of two or three dilatations with
progressively enlarging
balloons. HM was performed
laparoscopically in 88% cases
and was combined with an
anti-reﬂux procedure in 33%.
Mean follow up was 3.1 years
with a median of 2.6 years.
Twenty patients failing graded
PD crossed over to the LHM
group, these were initially
included to the ED and
subsequently to the LHM group.
Retrospective
cohort study
(level 3)
Treatment
success
(deﬁned as
dysphagia less
than 3 times/
week or
freedom from
subsequent
intervention).
Single ED: 62% at 6
months, 50%, 38% and
28% at 2, 4 and 6 years,
respectively.
Graded ED: 90% at 6
months, 82%, 64% and
44% at 2, 4 and 6 years,
respectively.
LHM: 89% at 6 months,
86%, 78% and 57% at 2, 4
and 6 years,
respectively.
Authors note that graded ED
and LHM provide similar results
in short and long-term follow
up.
Single ED has a higher risk of
symptom recurrence requiring
further treatment.
Factors associated with the
need for additional ED were
younger age, male sex, wider
oesophagus at timed barium
oesophagogram and no
improvement in barium height
in the ﬁrst month.
Limitations:
Retrospective study.
Patients with refractory disease
not corresponding to ED were
switched to the LHM group
which may have bias the
results.
(continued on next page)
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Table 1 (continued )
Author, date, journal
and country
Patient group Study type (level of
evidence)
Outcomes Key results Comments
Gutschow et al., 2010,
Langenbecks
Archives of Surgery,
Germany8
Retrospective study of 43
patients comparing different
treatment modalities for
achalasia.
Patients were treated with
endoscopic botulinum toxin
injection (n¼ 7), ED (n¼ 16),
LHM post-failed ED (n¼ 14) of
which 93% previously
underwent multiple ED and
LHM (n¼ 6).
Achalasia related symptoms
were evaluated through a
structured interview according
to Eckardt score pre- and post-
treatment.
Retrospective
cohort study
(level 3)
Primary:
clinical
remission
(deﬁned as
complete
absence of
symptoms,
Eckardt score
improvement
>2 or Eckardt
score< 3).
Secondary:
mortality,
morbidity,
post-
interventional
hospitalization
(days).
EBTI¼ 28.6%
ED¼ 93.8%
ED-LHM¼ 64.3%
LHM¼ 83.3%
Cumulative remission
for the surgical
treatment
group¼ 70.0% (ED-
LHM+ LHM).
Cumulative remission
for ﬁrst line PD¼ 50%
(considering ED-LHM
as treatment failures).
0% in all groups
Low ED¼ 1 (0e7)
ED-LHM¼ 6 (4e13)
LHM¼ 5 (4e8)
Authors conclude that LHM is
the most effective ﬁrst line
treatment for achalasia.
Clinical outcomes of LHM when
used as a second line treatment,
post-failed ED, were affected by
previous interventions.
Poor symptomatic outcome
was correlated to a low
esophageal sphincter pressure
during pre-therapeutic
manometry (P¼ 0.03) and to
sigmoid-shaped esophageal
dilatation (P¼ 0.06)
Limitations:
Patients were not matched for
number and type of
interventions prior to
treatment.
Limited long-term follow up.
Reynoso et al., 2010,
Surgical Endoscopy,
USA9
Study analyzing retrospective
data of 1882 hospitalized
patients with achalasia.
Authors used a common
hospital database, which
allowed correlation between
patient risk and treatment
outcome.
A total of 1390 patients were
treated with LHM, of these 1317
were at the minor/moderate
illness severity group and 73 in
the major/extreme illness
severity group.
The ED group consisted of 492
patients, 246 from the minor/
moderate severity group and
246 from the major/extreme
from the major/extreme illness
severity group.
Patients were not balanced
with respect to age.
Signiﬁcantly more patients
aged over 65 years were treated
with ED (53.3% vs. 21.3%,
P< 0.001).
Retrospective
cohort study
(level 3)
Oesophageal
perforation risk
Mortality (%)
Morbidity (%)
Length of
hospital stay
(days,
mean SD)
30-Day
readmission (%)
Cumulative: LHM vs.
ED¼ 0.4% vs. 2.4%,
P< 0.001.
LHM vs. ED¼ 0.07 vs.
1.22, P< 0.05.
LHM vs. ED¼ 11.01% vs.
12.31%, P> 0.05.
Overall: LHM vs.
ED¼ 2.59 2.91 vs.
8.3 9.08, P< 0.05.
Minor/moderate: LHM
vs. ED¼ 0.38% vs. 7.32%,
P< 0.001.
Major/extreme: LHM
vs. ED¼ 1.97% vs. 6.72%,
P> 0.05.
Overall: LHM vs.
PD¼ 0.65% vs. 7.20%,
P< 0.05.
Authors conclude that both
treatments are safe and
effective.
Correlation between patients'
co-morbidities and treatment
outcome revealed LHM was
associated with an improved
outcome proﬁle in the minor/
moderate group whereas ED
showed greater improvement
in the in the major/extreme
illness severity group.
Limitations:
Administrative data used so
limited data on clinical
remission or quality of life post-
treatment.
Inadequate information on
fundoplication, extend of
myotomy and dilatation
technique
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tion techniques, extend of myotomy or dilation technique.7. Clinical bottom line
Existing evidence shows that LHM is associated with improved
post-operative symptoms and reduced clinical relapse rates
compared to ED. Satisfactory clinical outcomes with ED often
require repeat procedures performed over time and are associated
with an increased risk of oesophageal perforation compared to LHM.
Oneprospective randomized study showedno signiﬁcant difference
in post-operative outcomes between LHM and ED but this was
limited by lack of standardization in the endoscopic dilatation
procedure, limited reporting of complications and poor long-term
follow up. Current evidence shows oesophageal perforation dur-
ing LHM may be successfully managed intra-operatively but in ED
usually requires further laparoscopic or open operative interven-
tion. Fundoplication during LHM is associated with reduced inci-
dence of post-operative gastro-oesophageal reﬂux disease. There is
an increased risk of clinical relapse regardless of the treatment in
patients with a sigmoid-shaped oesophagus or reducedoesophageal sphincter pressure assessed during pre-treatment
manometry. Current studies are limited by study design, varia-
tions in operative technique and dilatation regimens, and limited
followup times. Further higher power studiesmatching patients for
disease severity and surgical technique with longer follow up may
enable greater understanding of differences in outcomes and
improved patient selection for different treatment regimens.
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